Molecular mimicry between streptococcal pyrogenic exotoxin B and endothelial cells

Laboratory Investigation

Volumn 90, Issue 10, 2010, Pages 1492-1506

  Luo, Yueh Hsia ^a   Chuang, Woei Jer ^a   Wu, Jiunn Jong ^a   Lin, Ming T ^a   Liu, Ching Chuan ^b   Lin, Pao Yen ^a   Roan, Jun Neng ^a   Wong, Tak Wah ^a   Chen, Yuh Ling ^a   Lin, Yee Shin ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

autoantibodies; epitope; group A streptococcus; rheumatic heart disease; streptococcal pyrogenic exotoxin B

Indexed keywords

BACTERIAL TOXIN; EXOTOXIN B; IMMUNOGLOBULIN G; N ACETYL BETA GLUCOSAMINIDASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DEATH; COMPLEMENT ACTIVATION; ENDOTHELIUM CELL; ENZYME BINDING; FEMALE; HEART VALVE; HUMAN; HUMAN CELL; IMMUNOGLOBULIN DEPOSITION; MOLECULAR MIMICRY; MOUSE; NONHUMAN; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; STREPTOCOCCUS GROUP A;

ACETYLGLUCOSAMINE; AMINO ACID SEQUENCE; ANIMALS; AUTOANTIBODIES; AUTOIMMUNITY; BACTERIAL PROTEINS; CROSS REACTIONS; ENDOTHELIAL CELLS; EXOTOXINS; HUMANS; IMMUNIZATION; IMMUNODOMINANT EPITOPES; MICE; MOLECULAR MIMICRY; RHEUMATIC HEART DISEASE; SERUM ALBUMIN, BOVINE; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES;

EID: 77957261597     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.2010.93     Document Type: Article

References (63)

1. Bisno AL, Brito MO, Collins CM. Molecular basis of group A streptococcal virulence. Lancet Infect Dis 2003;3:191-200.
2. Carapetis JR, Steer AC, Mulholland EK, et al. The global burden of group A streptococcal diseases. Lancet Infect Dis 2005;5:685-694. (Pubitemid 41505357)
3. Carapetis JR, McDonald M, Wilson NJ. Acute rheumatic fever. Lancet 2005;366:155-168. (Pubitemid 40991218)
4. Cunningham MW. Pathogenesis of group A streptococcal infections. Clin Microbiol Rev 2000;13:470-511.
5. Graham MR, Smoot LM, Lei B, et al. Toward a genome-scale understanding of group A streptococcus pathogenesis. Curr Opin Microbiol 2001;4:65-70. (Pubitemid 32126899)
6. Currie BJ. Group A streptococcal infections of the skin: molecular advances but limited therapeutic progress. Curr Opin Infect Dis 2006;19:132-138.
7. McDonald M, Currie BJ, Carapetis JR. Acute rheumatic fever: a chink in the chain that links the heart to the throat? Lancet Infect Dis 2004;4:240-245. (Pubitemid 38407307)
8. Tart AH, Walker MJ, Musser JM. New understanding of the group A streptococcus pathogenesis cycle. Trends Microbiol 2007;15: 318-325.
9. Guilherme L, Kalil J, Cunningham M. Molecular mimicry in the autoimmune pathogenesis of rheumatic heart disease. Autoimmunity 2006;39:31-39. (Pubitemid 43878518)
10. Kirvan CA, Swedo SE, Heuser JS, et al. Mimicry and autoantibodymediated neuronal cell signaling in Sydenham chorea. Nat Med 2003;9:914-920.
11. Martins TB, Veasy LG, Hill HR. Antibody responses to group A streptococcal infections in acute rheumatic fever. Pediatr Infect Dis J 2006;25:832-837. (Pubitemid 44325787)
12. Carapetis JR. Rheumatic heart disease in developing countries. N Engl J Med 2007;357:439-441. (Pubitemid 47204872)
13. Marijon E, Ou P, Celermajer DS, et al. Prevalence of rheumatic heart disease detected by echocardiographic screening. N Engl J Med 2007;357:470-476. (Pubitemid 47204876)
14. Guilherme L, Cury P, Demarchi LM, et al. Rheumatic heart disease: proinflammatory cytokines play a role in the progression and maintenance of valvular lesions. Am J Pathol 2004;165:1583-1591. (Pubitemid 39435157)
15. Kudat H, Telci G, Sozen AB, et al. The role of HLA molecules in susceptibility to chronic rheumatic heart disease. Int J Immunogenet 2006;33:41-44.
16. Kurahara D, Tokuda A, Grandinetti A, et al. Ethnic differences in risk for pediatric rheumatic illness in a culturally diverse population. J Rheumatol 2002;29:379-383. (Pubitemid 34118791)
17. Ramasawmy R, Fae KC, Spina G, et al. Association of polymorphisms within the promoter region of the tumor necrosis factor-a with clinical outcomes of rheumatic fever. Mol Immunol 2007;44:1873-1878. (Pubitemid 44827261)
18. Cunningham MW, Antone SM, Smart M, et al. Molecular analysis of human cardiac myosin-cross-reactive B- and T-cell epitopes of the group A streptococcal M5 protein. Infect Immun 1997;65:3913-3923. (Pubitemid 27398159)
19. Cunningham MW. T cell mimicry in inflammatory heart disease. Mol Immunol 2004;40:1121-1127. (Pubitemid 38221194)
20. Ellis NMJ, Li Y, Hildebrand W, et al. T cell mimicry and epitope specificity of cross-reactive T cell clones from rheumatic heart disease. J Immunol 2005;175:5448-5456. (Pubitemid 41456431)
21. Fae KC, da Silva DD, Oshiro SE, et al. Mimicry in recognition of cardiac myosin peptides by heart-intralesional T cell clones from rheumatic heart disease. J Immunol 2006;176:5662-5670.
22. Guilherme L, Fae K, Oshiro SE, et al. Molecular pathogenesis of rheumatic fever and rheumatic heart disease. Expert Rev Mol Med 2005;7:1-15. (Pubitemid 43118220)
23. Roberts S, Kosanke S, Dunn ST, et al. Pathogenic mechanisms in rheumatic carditis: focus on valvular endothelium. J Infect Dis 2001;183:507-511. (Pubitemid 32105611)
24. Cunningham MW. Autoimmunity and molecular mimicry in the pathogenesis of post-streptococcal heart disease. Front Biosci 2003;8:s533-s543. (Pubitemid 39144355)
25. Fenderson PG, Fischetti VA, Cunningham MW. Tropomyosin shares immunologic epitopes with group A streptococcal M proteins. J Immunol 1989;142:2475-2481.
26. Gulizia JM, Cunningham MW, McManus BM. Immunoreactivity of antistreptococcal monoclonal antibodies to human heart valves. Evidence for multiple cross-reactive epitopes. Am J Pathol 1991;138:285-301.
27. Malkiel S, Liao L, Cunningham MW, et al. T-cell-dependent antibody response to the dominant epitope of streptococcal polysaccharide, N-acetyl-glucosamine, is cross-reactive with cardiac myosin. Infect Immun 2000;68:5803-5808.
28. Oliveira DBG. Poststreptococcal glomerulonephritis: getting to know an old enemy. Clin Exp Immunol 1997;107:8-10.
29. Poon-King R, Bannan J, Viteri A, et al. Identification of an extracellular plasmin binding protein from nephritogenic streptococci. J Exp Med 1993;178:759-763. (Pubitemid 23218228)
30. Rodriguez-Iturbe B, Batsford S. Pathogenesis of poststreptococcal glomerulonephritis a century after Clemens von Pirquet. Kidney Int 2007;71:1094-1104. (Pubitemid 46809132)
31. Yoshizawa N, Oshima S, Takeuchi A, et al. Experimental acute glomerulonephritis induced in the rabbit with a specific streptococcal antigen. Clin Exp Immunol 1997;107:61-67. (Pubitemid 27019812)
32. Batsford SR, Mezzano S, Mihatsch M, et al. Is the nephritogenic antigen in post-streptococcal glomerulonephritis pyrogenic exotoxin B (SPE B) or GAPDH? Kidney Int 2005;68:1120-1129. (Pubitemid 43246428)
33. Cu GA, Mezzano S, Bannan JD, et al. Immunohistochemical and serological evidence for the role of streptococcal proteinase in acute post-streptococcal glomerulonephritis. Kidney Int 1998;54:819-826. (Pubitemid 28397399)
34. Parra G, Rodriguez-Iturbe B, Batsford S, et al. Antibody to streptococcal zymogen in the serum of patients with acute glomerulonephritis: a multicentric study. Kidney Int 1998;54:509-517. (Pubitemid 28357413)
35. Luo YH, Kuo CF, Huang KJ, et al. Streptococcal pyrogenic exotoxin B antibodies in a mouse model of glomerulonephritis. Kidney Int 2007;72:716-724.
36. Chen CY, Luo SC, Kuo CF, et al. Maturation processing and characterization of streptopain. J Biol Chem 2003;278: 17336-17343.
37. Kuo CF, Luo YH, Lin HY, et al. Histopathologic changes in kidney and liver correlate with streptococcal pyrogenic exotoxin B production in the mouse model of group A streptococcal infection. Microb Pathog 2004;36:273-285.
38. Ades EW, Candal FJ, Swerlick RA, et al. HMEC-1: establishment of an immortalized human microvascular endothelial cell line. J Invest Dermatol 1992;99:683-690.
39. Shikhman AR, Greenspan NS, Cunningham MW. A subset of mouse monoclonal antibodies cross-reactive with cytoskeletal proteins and group A streptococcal M proteins recognizes N-acetyl-b-Dglucosamine. J Immunol 1993;151:3902-3913.
40. Frank R. The SPOT-synthesis technique. Synthetic peptide arrays on membrane supports-principles and applications. J Immunol Methods 2002;267:13-26. (Pubitemid 34804809)
41. Song CY, Chen WL, Yang MC, et al. Epitope mapping of a monoclonal antibody specific to bovine dry milk. Involvement of residues 66-76 of strand D in thermal denatured b-lactoglobulin. J Biol Chem 2005;280:3574-3582.
42. Simon A, Wilhelmi M, Steinhoff G, et al. Cardiac valve endothelial cells: relevance in the long-term function of biologic valve prostheses. J Thorac Cardiovasc Surg 1998;116:609-616. (Pubitemid 28460627)
43. Kaplan MH, Bolande R, Rakita L, et al. Presence of bound immunoglobulins and complement in the myocardium in acute rheumatic fever. Association with cardiac failure. N Engl J Med 1964;271:637-645.
44. Kaplan MH. Autoantibodies to heart and rheumatic fever: the induction of autoimmunity to heart by streptococcal antigen cross-reactive with heart. Ann NY Acad Sci 1965;124: 904-915.
45. Zabriskie JB, Freimer EH. An immunological relationship between the group A streptococcus and mammalian muscle. J Exp Med 1966;124:661-678.
46. Zabriskie JB, Hsu KC, Seegal BC. Heart-reactive antibody associated with rheumatic fever: characterization and diagnostic significance. Clin Exp Immunol 1970;7:147-159.
47. Dudding BA, Ayoub EM. Persistence of streptococcal group A antibody in patients with rheumatic valvular disease. J Exp Med 1968;128: 1081-1098.
48. Cunningham MW, Swerlick RA. Polyspecificity of antistreptococcal murine monoclonal antibodies and their implications in autoimmunity. J Exp Med 1986;164:998-1012.
49. Cunningham MW, Hall NK, Krisher KK, et al. A study of anti-group A streptococcal monoclonal antibodies cross-reactive with myosin. J Immunol 1986;136:293-298.
50. Cunningham MW, McCormack JM, Talaber LR, et al. Human monoclonal antibodies reactive with antigens of the group A streptococcus and human heart. J Immunol 1988;141:2760-2766. (Pubitemid 18263065)
51. Shikhman AR, Greenspan NS, Cunningham MW. A subset of mouse monoclonal antibodies cross-reactive with cytoskeletal proteins and group A streptococcal M proteins recognizes N-acetyl-beta-Dglucosamine. J Immunol 1993;151:3902-3913.
52. Shikhman AR, Cunningham MW. Immunological mimicry between N-acetyl-beta-D-glucosamine and cytokeratin peptides. Evidence for a microbially driven anti-keratin antibody response. J Immunol 1994;152:4375-4387. (Pubitemid 24134395)
53. Sapru RP, Ganguly NK, Sharma S, et al. Cellular reaction to group A beta-haemolytic streptococcal membrane antigen and its relation to complement levels in patients with rheumatic heart disease. Brit Med J 1977;2:422-424. (Pubitemid 8158936)
54. Leask RL, Jain N, Butany J. Endothelium and valvular diseases of the heart. Microsc Res Tech 2003;60:129-137. (Pubitemid 36125701)
55. Galvin JE, Hemric ME, Ward K, et al. Cytotoxic mAb from rheumatic carditis recognizes heart valves and laminin. J Clin Invest 2000;106:217-224. (Pubitemid 30483125)
56. Cunningham MW. Molecular mimicry, autoimmunity and infection in the pathogenesis of rheumatic fever. Int Congress Series 2006;1289:14-19. (Pubitemid 43589851)
57. Goldstein I, Halpern B, Robert L. Immunological relationship between streptococcus A polysaccharide and the structural glycoproteins of heart valve. Nature 1967;213:44-47.
58. Turner JR, Tartakoff AM, Greenspan NS. Cytologic assessment of nuclear and cytoplasmic O-linked N-acetylglucosamine distribution by using anti-streptococcal monoclonal antibodies. Proc Natl Acad Sci USA 1990;87:5608-5612. (Pubitemid 20240336)
59. Pockley AG. Heat shock proteins, inflammation, and cardiovascular disease. Circulation 2002;105:1012-1017. (Pubitemid 34184583)
60. Tontsch D, Pankuweit S, Maisch B. Autoantibodies in the sera of patients with rheumatic heart disease: characterization of myocardial antigens by two-dimensional immunoblotting and N-terminal sequence analysis. Clin Exp Immunol 2000;121: 270-274. (Pubitemid 30659764)
61. Olive C. Progress in M-protein-based subunit vaccines to prevent rheumatic fever and rheumatic heart disease. Curr Opin Mol Ther 2007;9:25-34. (Pubitemid 46438446)
62. Batzloff MR, Pandey M, Olive C, et al. Advances in potential M-protein peptide-based vaccines for preventing rheumatic fever and rheumatic heart disease. Immunol Res 2006;35:233-248. (Pubitemid 46020725)
63. Kuo CF, Wu JJ, Lin KY, et al. Role of streptococcal pyrogenic exotoxin B in the mouse model of group A streptococcal infection. Infect Immun 1998;66:3931-3935. (Pubitemid 28347857)